loadpatents
Patent applications and USPTO patent grants for ASHRAFIAN; Houman.The latest application filed is for "novel uses".
Patent | Date |
---|---|
Novel Uses App 20210236513 - JOLLES; Stephen ;   et al. | 2021-08-05 |
Clozapine For The Treatment Of A Immunoglobulin Driven B Cell Disease App 20210236512 - JOLLES; Stephen ;   et al. | 2021-08-05 |
Clozapine For The Treatment Of Ig-e Driven B Cell Diseases App 20210137941 - JOLLES; Stephen ;   et al. | 2021-05-13 |
Treatment of heart failure Grant 9,468,634 - Ashrafian , et al. October 18, 2 | 2016-10-18 |
Treatment of heart failure Grant 9,457,017 - Ashrafian , et al. October 4, 2 | 2016-10-04 |
Perhexiline For Use In The Treatment Of Hypertrophic Cardiomyopathy (hcm) App 20140194466 - ASHRAFIAN; Houman ;   et al. | 2014-07-10 |
Perhexiline for use in the treatment of hypertrophic cardiomyopathy (HCM) Grant 8,697,728 - Ashrafian , et al. April 15, 2 | 2014-04-15 |
Treatment Of Heart Failure App 20130210720 - ASHRAFIAN; Houman ;   et al. | 2013-08-15 |
Treatment Of Heart Failure App 20130210719 - ASHRAFIAN; Houman ;   et al. | 2013-08-15 |
Treatment of heart failure Grant 8,440,697 - Ashrafian , et al. May 14, 2 | 2013-05-14 |
Perhexiline For Use In The Treatment Of Hypertrophic Cardiomyopathy (hcm) App 20120122925 - Ashrafian; Houman ;   et al. | 2012-05-17 |
TREATMENT OF HFnEF App 20100331364 - Ashrafian; Houman ;   et al. | 2010-12-30 |
Treatment of Heart Failure App 20100008908 - Ashrafian; Houman ;   et al. | 2010-01-14 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.